Collplant Biotechnologies Ltd (NASDAQ:CLGN)
| 6.77 Delayed Data As of Sep 30 |  +0.22 / +3.36%Today’s Change | 6.18 Today|||52-Week Range 23.00 | -58.62% Year-to-Date |
Latest CLGN News | Press Releases
No recent news for Collplant Biotechnologies Ltd.
Today’s Trading
| Previous close | 6.55 |
| Today’s open | 6.77 |
| Day’s range | 6.77 - 6.77 |
| Volume | 100 |
| Average volume (3 months) | 17,100 |
| Market cap | $69.8M |
Data as of 2:30pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -6,900.00% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +154.86% |
| P/E ratio | NM |
| Price/Sales | 12.52 |
| Price/Book | 1.50 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ENLVEnlivex Therapeutics... | +0.13 | +3.14% |
| RWLKRewalk Robotics Ltd | +0.05 | +5.36% |
| APTAlpha Pro Tech Ltd | -0.01 | -0.25% |
| SIENSientra Inc | +0.04 | +6.63% |
Data as of 4:01pm ET, 09/30/2022
Financials
| Next reporting date | December 2, 2022 |
| EPS forecast (this quarter) | -$0.31 |
| Annual revenue (last year) | $15.6M |
| Annual profit (last year) | $237.0K |
| Net profit margin | 1.52% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Rehovot, Tel Aviv |
Forecasts
